CIRIUS THERAPEUTICS
Cirius Therapeutics is a clinical-stage company that develops insulin sensitizer for the treatment of non-alcoholic steatohepatitis. The company developing MSDC-0602K, a next-generation insulin sensitizer for the treatment of nonalcoholic steatohepatitis (NASH). MSDC-0602K is currently being evaluated in a Phase 2b clinical trial. Through its novel insulin-sensitizing mechanism of action, MSDC-0602K has the potential to resolve the underlying pathophysiology of NASH. Circius Therapeutics focused on the development and commercialization of innovative therapies for the treatment of liver and metabolic diseases. It was founded in 2015 and is based in Kalamazoo, Michigan, United States.
CIRIUS THERAPEUTICS
Industry:
Biopharma Biotechnology Medical Device Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Kalamazoo, Michigan, United States
Country:
United States
Website Url:
http://www.ciriustx.com
Total Employee:
11+
Status:
Active
Contact:
(269)343-6732
Total Funding:
49 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics WordPress Google Universal Analytics Mobile Non Scaleable Content Sitelinks Search Box Euro Organization Schema
Similar Organizations
Alios BioPharma
Alios BioPharma is a biotechnology company developing novel medicines for the treatment of viral diseases.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series A - Cirius Therapeutics
Adams Street Partners
Adams Street Partners investment in Series A - Cirius Therapeutics
Novo Holdings
Novo Holdings investment in Series A - Cirius Therapeutics
Hopen Life Science Ventures
Hopen Life Science Ventures investment in Series A - Cirius Therapeutics
Novo Holdings
Novo Holdings investment in Series A - Cirius Therapeutics
Renaissance Venture Capital
Renaissance Venture Capital investment in Series A - Cirius Therapeutics
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series A - Cirius Therapeutics
Adams Street Partners
Adams Street Partners investment in Series A - Cirius Therapeutics
Official Site Inspections
http://www.ciriustx.com Semrush global rank: 8.14 M Semrush visits lastest month: 359
- Host name: a16e665f42988324c.awsglobalaccelerator.com
- IP address: 76.223.105.230
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
